20-07-2023, 09:49

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as the First-line Treatment of Extensive-stage Small Cell Lung Cancer
Globe Newswire20-07-2023, 09:49
29-06-2023, 12:59

Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer
Globe Newswire29-06-2023, 12:59